Gene Therapy of the β Hemoglobinopathies: Success and Challenges
Hemoglobin(2019)
Abstract
The very large number of known mutations responsible for the β-thalassemias, renders gene therapy by gene addition ideally suited for regulatory product approval rather than the many mutation-speci...
MoreTranslated text
Key words
hemoglobinopathies,gene therapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined